Financhill

Seasonal Stocks

Per Page: 24
Company
Last Closing Price
% Increase 
CMLS
Cumulus Media
2.68
5425.32%
Annualized %:
28211.69%
Historical % of Increase:
83.33%
View Chart
GSHD
Goosehead Insurance
55.50
35.73%
Annualized %:
185.82%
Historical % of Increase:
80%
View Chart
AXDX
Accelerate Diagnostics
0.93
35.72%
Annualized %:
185.74%
Historical % of Increase:
80.77%
View Chart
NIO
NIO
4.49
35.54%
Annualized %:
184.83%
Historical % of Increase:
80%
View Chart
FNKO
Funko
6.20
33.43%
Annualized %:
173.81%
Historical % of Increase:
83.33%
View Chart
NTLA
Intellia Therapeutics
20.76
33.3%
Annualized %:
173.16%
Historical % of Increase:
85.71%
View Chart
REPL
Replimune Group
6.42
32.96%
Annualized %:
171.37%
Historical % of Increase:
80%
View Chart
LVO
LiveOne
1.90
30.5%
Annualized %:
158.61%
Historical % of Increase:
83.33%
View Chart
OPRA
Opera
13.34
29.5%
Annualized %:
153.39%
Historical % of Increase:
80%
View Chart
RH
RH
248.91
28.86%
Annualized %:
150.06%
Historical % of Increase:
81.82%
View Chart
TTD
The Trade Desk
84.73
28.75%
Annualized %:
149.48%
Historical % of Increase:
85.71%
View Chart
VRT
Vertiv Holdings
93.49
27.79%
Annualized %:
144.49%
Historical % of Increase:
80%
View Chart
MDB
MongoDB
383.80
26.67%
Annualized %:
138.7%
Historical % of Increase:
83.33%
View Chart
ZS
Zscaler
177.05
26.23%
Annualized %:
136.39%
Historical % of Increase:
83.33%
View Chart
SWAV
Shockwave Medical
330.00
26.02%
Annualized %:
135.29%
Historical % of Increase:
80%
View Chart
KOD
Kodiak Sciences
3.28
25.97%
Annualized %:
135.04%
Historical % of Increase:
80%
View Chart
ARCT
Arcturus Therapeutics Holdings
26.55
24.52%
Annualized %:
127.52%
Historical % of Increase:
80%
View Chart
NTRA
Natera
91.66
24.12%
Annualized %:
125.4%
Historical % of Increase:
87.5%
View Chart
INMB
INmune Bio
11.29
21.55%
Annualized %:
112.06%
Historical % of Increase:
80%
View Chart
CELC
Celcuity
15.92
20.5%
Annualized %:
106.62%
Historical % of Increase:
83.33%
View Chart
YMAB
Y-mAbs Therapeutics
14.71
18.88%
Annualized %:
98.2%
Historical % of Increase:
80%
View Chart
CRSP
CRISPR Therapeutics AG
53.91
18.88%
Annualized %:
98.2%
Historical % of Increase:
85.71%
View Chart
EEX
Emerald Holding
5.86
18.75%
Annualized %:
97.5%
Historical % of Increase:
83.33%
View Chart
PLMR
Palomar Holdings
79.50
18.54%
Annualized %:
96.39%
Historical % of Increase:
80%
View Chart
No results

Investing News

Cava vs. Dutch Bros Stock, Which Is Best?

Cava vs. Dutch Bros Stock, Which Is Best?

Restaurant and coffee chains operate in a highly competitive industry that does not offer many growth levers beyond growing locations. In spite of the challenges, CAVA Group, Inc. (NYSE:CAVA) and Dutch Bros Inc. (NYSE:BROS) are both gaining significant traction and attracting new shareholders. But if you had to choose among them, which is the better […]

Read Article

How High Will Madrigal Pharmaceuticals Go?

How High Will Madrigal Pharmaceuticals Go?

The FDA said yes to Madrigal Pharmaceuticals’ (MDGL) new drug, Rezdiffra, which led to its stock price shooting up but the momentum quickly subsided so what does the future hold? As the biotechnology industry is once again bubbling with prominent mergers and acquisitions, accelerated FDA approvals, and breakthrough developments, now may be as good a […]

Read Article

Why Did Bill Gates Buy Berkshire Hathaway?

Why Did Bill Gates Buy Berkshire Hathaway?

Bill Gates is a technology icon. Warren Buffett is an investing icon. The two men also happen to be very good friends with a three-decade-long relationship. Over that time, they have partnered on many ventures, both political and philanthropic. Because of the friendship the two men share, it may come as no surprise that Gates, […]

Read Article

Why Did Buffett Invest In Chevron? 

Why Did Buffett Invest In Chevron? 

Warren Buffett, the guru of value investing best known buying and holding stock has been snapping up shares of Chevron Corporation (NYSE:CVX), one of the most prominent energy companies. Buffett-controlled Berkshire Hathaway reduced its Chevron holding initially last year but in Q4 the company unexpectedly changed its course from selling to buying 15.8 million shares. […]

Read Article

How Did Deborah Meaden Make Her Money?

How Did Deborah Meaden Make Her Money?

Deborah Meaden grew up in an entrepreneurial household, but she didn’t start her life rich. Her family owned an amusement arcade that she eventually came to manage when she grew older. Today, Deborah Meaden is best known as an investor on the BBC show Dragons’ Den. The show’s name is derived from its original Japanese […]

Read Article

1 Warren Buffett ETF To Buy?

1 Warren Buffett ETF To Buy?

One reason the “Oracle of Omaha” became a billionaire was because he took early stakes in some of the biggest brands in the world, including Apple and Coca-Cola. But it wasn’t just his stock-picking prowess that earned the world-famous investor his accolades. Indeed one researcher recently claimed Buffett’s real skill was figuring out how to […]

Read Article

More Investing News

The #1 Stock Analysis Tool to Make Smarter Buy and Sell Decisions

Get started at Financhill, the #1 investment research platform that is your one-stop shop for finding the best trade ideas today.

  • Top Rated Stock Ideas
    Financhill Stock Score is a proprietary stock rating engine that independently evaluates every company based on fundamental, technical, and sentiment criteria so you can find the highest rated stocks in the S&P 500, NASDAQ and NYSE.
  • Best Stock Tools Platform
    Whether you are looking for the best blue chip stocks, top dividend stocks, most shorted stocks, cheapest stocks today, highest dividend stocks or best stocks under $50, Financhill has got you covered and has so much more.
  • Stocks Set To Soar & Crash
    Financhill spots seasonal patterns in thousands of stocks so you can easily screen for the best stocks at this time of year. Want to know what stocks could rise 11% over the next 7 weeks with 91% accuracy based on past history? Our Seasonality Screener will surface the hottest stocks right now.
Learn More

Featured in:

CNBC
The Wall Street Journal
Chicago Tribune
Barrons
MSN
Reuters